Medical Properties Trust Files Q1 2024 10-Q

TL;DR

MPW dropped its Q1 2024 10-Q. Financials are in.

AI Summary

Medical Properties Trust, Inc. (MPW) filed its 10-Q for the period ending March 31, 2024. The company reported its financial results and provided updates on its operations. Key financial details and operational highlights are detailed within the filing.

Why It Matters

This filing provides investors with the latest financial performance and operational status of Medical Properties Trust, Inc., crucial for understanding its current health and future prospects.

Risk Assessment

Risk Level: medium — As a real estate investment trust, MPW is subject to market fluctuations and specific industry risks, which are detailed in its SEC filings.

Key Numbers

• N/A — Total Assets (Specific asset figures are not provided in this header-level data.)
• N/A — Total Liabilities (Specific liability figures are not provided in this header-level data.)
• N/A — Revenue (Specific revenue figures are not provided in this header-level data.)

Key Players & Entities

• Medical Properties Trust, Inc. (company) — Filer of the 10-Q
• MPT Operating Partnership, L.P. (company) — Related entity filing
• 20240331 (date) — End of reporting period

FAQ

Key Financial Figures

• $0.001 — ch registered Common stock, par value $0.001 per share, of Medical Properties Trust,
• $0 — llion shares of common stock, par value $0.001, outstanding. EXPLANATORY NOTE

Filing Documents

• mpw-20240331.htm (10-Q) — 2532KB
• mpw-ex10_1.htm (EX-10.1) — 66KB
• mpw-ex10_2.htm (EX-10.2) — 79KB
• mpw-ex31_1.htm (EX-31.1) — 13KB
• mpw-ex31_2.htm (EX-31.2) — 12KB
• mpw-ex31_3.htm (EX-31.3) — 12KB
• mpw-ex31_4.htm (EX-31.4) — 12KB
• mpw-ex32_1.htm (EX-32.1) — 10KB
• mpw-ex32_2.htm (EX-32.2) — 10KB
• 0000950170-24-065929.txt ( ) — 10635KB
• mpw-20240331.xsd (EX-101.SCH) — 1858KB
• mpw-20240331_htm.xml (XML) — 1699KB

— FINANCIAL INFORMATION

PART I — FINANCIAL INFORMATION 3

Financial Statements

Item 1 Financial Statements 3 Medical Properties Trust, Inc. and Subsidiaries Condensed Consolidated Balance Sheets at March 31, 2024 and December 31, 2023 3 Condensed Consolidated Statements of Net Income for the Three Months Ended March 31, 2024 and 2023 4 Condensed Consolidated Statements of Comprehensive (Loss) Income for the Three Months Ended March 31, 2024 and 2023 5 Condensed Consolidated Statements of Equity for the Three Months Ended March 31, 2024 and 2023 6 Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2024 and 2023 7 MPT Operating Partnership, L.P. and Subsidiaries Condensed Consolidated Balance Sheets at March 31, 2024 and December 31, 2023 8 Condensed Consolidated Statements of Net Income for the Three Months Ended March 31, 2024 and 2023 9 Condensed Consolidated Statements of Comprehensive (Loss) Income for the Three Months Ended March 31, 2024 and 2023 10 Condensed Consolidated Statements of Capital for the Three Months Ended March 31, 2024 and 2023 11 Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2024 and 2023 12 Medical Properties Trust, Inc. and MPT Operating Partnership, L.P. and Subsidiaries Notes to Condensed Consolidated Financial Statements 13

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2 Management's Discussion and Analysis of Financial Condition and Results of Operations 28

Quantitative and Qualitative Disclosures about Market Risk

Item 3 Quantitative and Qualitative Disclosures about Market Risk 38

Controls and Procedures

Item 4 Controls and Procedures 39

— OTHER INFORMATION

PART II — OTHER INFORMATION 41

Legal Proceedings

Item 1 Legal Proceedings 41

A Risk Factors

Item 1 A Risk Factors 41

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 42

Defaults Upon Senior Securities

Item 3 Defaults Upon Senior Securities 43

Mine Safety Disclosures

Item 4 Mine Safety Disclosures 43

Other Information

Item 5 Other Information 43

Exhibits

Item 6 Exhibits 44 SIGNATURE 45 2

— FINANC IAL INFORMATION

PART I — FINANC IAL INFORMATION

Finan cial Statements

Item 1. Finan cial Statements. MEDICAL PROPERTIES TRU ST, INC. AND SUBSIDIARIES Condensed Consolida ted Balance Sheets March 31, 2024 December 31, 2023 (In thousands, except per share amounts) (Unaudited) (Note 2) Assets Real estate assets Land, buildings and improvements, intangible lease assets, and other $ 12,823,748 $ 13,237,187 Investment in financing leases 1,233,178 1,231,630 Real estate held for sale 295,130 — Mortgage loans 309,926 309,315 Gross investment in real estate assets 14,661,982 14,778,132 Accumulated depreciation and amortization ( 1,422,728 ) ( 1,407,971 ) Net investment in real estate assets 13,239,254 13,370,161 Cash and cash equivalents 224,340 250,016 Interest and rent receivables 34,492 45,059 Straight-line rent receivables 677,570 635,987 Investments in unconsolidated real estate joint ventures 1,450,482 1,474,455 Investments in unconsolidated operating entities 794,138 1,778,640 Other loans 426,971 292,615 Other assets 453,709 457,911 Total Assets $ 17,300,956 $ 18,304,844 Liabilities and Equity Liabilities Debt, net $ 10,098,723 $ 10,064,236 Accounts payable and accrued expenses 302,526 412,178 Deferred revenue 32,076 37,962 Obligations to tenants and other lease liabilities 163,264 156,603 Total Liabilities 10,596,589 10,670,979 Equity Preferred stock, $ 0.001 par value. Authorized 10,000 shares; no shares outstanding — — Common stock, $ 0.001 par value. Authorized 750,000 shares; issued and outstanding — 600,304 shares at March 31, 2024 and 598,991 shares at December 31, 2023 600 599 Additional paid-in capital 8,567,199 8,560,309 Retained deficit ( 1,846,862 ) ( 971,809 ) Accumulated other comprehensive (loss) income ( 18,838 ) 42,501 Total Medical Properties Trust, Inc. stockholders' equity 6,702,099 7,631,600 Non-controlling interest

View Full Filing

View this 10-Q filing on SEC EDGAR